Review



rabbit anti il 17rb  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Proteintech rabbit anti il 17rb
    Rabbit Anti Il 17rb, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+il+17rb/pm35343786-247-51-58?v=Proteintech
    Average 93 stars, based on 7 article reviews
    rabbit anti il 17rb - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    90
    Bioss mg l primary polyclonal rabbit antibodies against human il 17rb
    Mg L Primary Polyclonal Rabbit Antibodies Against Human Il 17rb, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+il+17rb/pm32686186-65-3-12?v=Bioss
    Average 90 stars, based on 1 article reviews
    mg l primary polyclonal rabbit antibodies against human il 17rb - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Beijing Solarbio Science rabbit anti-receptor b (il-17rb)
    Rabbit Anti Receptor B (Il 17rb), supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+il+17rb/pm37173731-136-37-41?v=Beijing+Solarbio+Science
    Average 90 stars, based on 1 article reviews
    rabbit anti-receptor b (il-17rb) - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    92
    Santa Cruz Biotechnology rabbit anti il 17rb

    Rabbit Anti Il 17rb, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+il+17rb/pmc10026849-327-25-28?v=Santa+Cruz+Biotechnology
    Average 92 stars, based on 1 article reviews
    rabbit anti il 17rb - by Bioz Stars, 2026-07
    92/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology rabbit anti mouse il 17rb

    Rabbit Anti Mouse Il 17rb, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+il+17rb/pm35914403-111-20-25?v=Santa+Cruz+Biotechnology
    Average 96 stars, based on 1 article reviews
    rabbit anti mouse il 17rb - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    93
    Proteintech rabbit anti il 17rb

    Rabbit Anti Il 17rb, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+il+17rb/pm35343786-247-51-58?v=Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit anti il 17rb - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    Proteintech rabbit anti il 17rb antibody
    FIGURE 1 | <t>IL-17RB</t> but not IL-17RA is involved in the skin wound healing of patients with DFU. (A–E) Relative mRNA expression of IL-25, IL-17RB, IL-17RA, IL-9 and VEGF in the wound edge skin from diabetic patients with DFU (n = 11) and normoglycemic individuals (n = 7), respectively. (F, G) Representative immunofluorescent staining for IL-17RB (green) and DAPI (blue) in the wound edge skin from diabetic patients with DFU and normoglycemic individuals. Scale bars, 20 mm. Quantification of the IL-17RB protein in the skin is shown in the histogram in G (n = 3, three views for each sample). *P < 0.05, **P < 0.01, ***P < 0.001. ns, no significance.
    Rabbit Anti Il 17rb Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+il+17rb/pm35126394-51-6-14?v=Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit anti il 17rb antibody - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    90
    GeneTex rabbit anti-human il-17rb gtx81729
    FIGURE 1 | <t>IL-17RB</t> but not IL-17RA is involved in the skin wound healing of patients with DFU. (A–E) Relative mRNA expression of IL-25, IL-17RB, IL-17RA, IL-9 and VEGF in the wound edge skin from diabetic patients with DFU (n = 11) and normoglycemic individuals (n = 7), respectively. (F, G) Representative immunofluorescent staining for IL-17RB (green) and DAPI (blue) in the wound edge skin from diabetic patients with DFU and normoglycemic individuals. Scale bars, 20 mm. Quantification of the IL-17RB protein in the skin is shown in the histogram in G (n = 3, three views for each sample). *P < 0.05, **P < 0.01, ***P < 0.001. ns, no significance.
    Rabbit Anti Human Il 17rb Gtx81729, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+il+17rb/pm31572359-81-27-30?v=GeneTex
    Average 90 stars, based on 1 article reviews
    rabbit anti-human il-17rb gtx81729 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    Journal: Cell reports

    Article Title: IL-17/CXCL5 signaling within the oligovascular niche mediates human and mouse white matter injury

    doi: 10.1016/j.celrep.2022.111848

    Figure Lengend Snippet:

    Article Snippet: The following primary antibodies were used: mouse anti-NF200 (1:200, Sigma), rabbit anti-MBP (1:500, Calbiochem), goat anti-PDGFRα (1:500; Neuromics), mouse anti-HA (1:1000, Biolegend), rabbit-Gst-π (1:1000, Millipore), rabbit anti-IL-17Rb (1:500, Santa Cruz Biotech), rat anti-CXCL5 (1:250, R&D) in PBS containing 5% goat or donkey serum and 0.3% Triton-X 100 (Sigma) overnight at 4°C.

    Techniques: Blocking Assay, Virus, Recombinant, Enzyme-linked Immunosorbent Assay, Luminex, Hybridization, Plasmid Preparation, Biomarker Discovery, Control, Software

    FIGURE 1 | IL-17RB but not IL-17RA is involved in the skin wound healing of patients with DFU. (A–E) Relative mRNA expression of IL-25, IL-17RB, IL-17RA, IL-9 and VEGF in the wound edge skin from diabetic patients with DFU (n = 11) and normoglycemic individuals (n = 7), respectively. (F, G) Representative immunofluorescent staining for IL-17RB (green) and DAPI (blue) in the wound edge skin from diabetic patients with DFU and normoglycemic individuals. Scale bars, 20 mm. Quantification of the IL-17RB protein in the skin is shown in the histogram in G (n = 3, three views for each sample). *P < 0.05, **P < 0.01, ***P < 0.001. ns, no significance.

    Journal: Frontiers in immunology

    Article Title: Interleukin-25-Mediated-IL-17RB Upregulation Promotes Cutaneous Wound Healing in Diabetic Mice by Improving Endothelial Cell Functions.

    doi: 10.3389/fimmu.2022.809755

    Figure Lengend Snippet: FIGURE 1 | IL-17RB but not IL-17RA is involved in the skin wound healing of patients with DFU. (A–E) Relative mRNA expression of IL-25, IL-17RB, IL-17RA, IL-9 and VEGF in the wound edge skin from diabetic patients with DFU (n = 11) and normoglycemic individuals (n = 7), respectively. (F, G) Representative immunofluorescent staining for IL-17RB (green) and DAPI (blue) in the wound edge skin from diabetic patients with DFU and normoglycemic individuals. Scale bars, 20 mm. Quantification of the IL-17RB protein in the skin is shown in the histogram in G (n = 3, three views for each sample). *P < 0.05, **P < 0.01, ***P < 0.001. ns, no significance.

    Article Snippet: Mouse anti-GAPDH antibody (Cat#: 60004-1-Ig) and rabbit anti-IL-17RB antibody (Cat#: 20673-1-AP) were obtained from Proteintech.

    Techniques: Expressing, Staining

    FIGURE 2 | Downregulation of IL-25-mediated-IL-17RB signaling contributes to the delay of wound healing in diabetic mice. 7-day wound biopsies within 2 mm of a wound edge were obtained from dorsal skin of control (CON) and diabetic (DM) mice. (A) Images of representative wounds on day 0 and day 11 after injury. (B) Quantification of time of wound closure (n = 5). (C) Representative images of Masson trichrome staining of dorsal skin sections from control and diabetic mice. Scale bars, 200 mm (left), 25 mm (right). (D) Quantification of collagen deposition in different groups (n = 3, three views for each sample). (E) Angiogenesis analysis by immunohistochemistry staining of CD31 in dorsal skin sections from control and diabetic mice. Scale bars, 25 mm. (F) Quantification of the vessel numbers is displayed in the graph (n = 3). (G, H) Relative mRNA expression of IL-25 and IL-17RB in the wound skin from control and diabetic mice (n = 3). (I, J) Representative immunofluorescent staining for IL-17RB (red) and DAPI (blue) in skin sections of wound edge from control and diabetic mice. Scale bars, 20 mm. Quantification of the IL-17RB protein expression in the mice skin is shown in the histogram in J (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001.

    Journal: Frontiers in immunology

    Article Title: Interleukin-25-Mediated-IL-17RB Upregulation Promotes Cutaneous Wound Healing in Diabetic Mice by Improving Endothelial Cell Functions.

    doi: 10.3389/fimmu.2022.809755

    Figure Lengend Snippet: FIGURE 2 | Downregulation of IL-25-mediated-IL-17RB signaling contributes to the delay of wound healing in diabetic mice. 7-day wound biopsies within 2 mm of a wound edge were obtained from dorsal skin of control (CON) and diabetic (DM) mice. (A) Images of representative wounds on day 0 and day 11 after injury. (B) Quantification of time of wound closure (n = 5). (C) Representative images of Masson trichrome staining of dorsal skin sections from control and diabetic mice. Scale bars, 200 mm (left), 25 mm (right). (D) Quantification of collagen deposition in different groups (n = 3, three views for each sample). (E) Angiogenesis analysis by immunohistochemistry staining of CD31 in dorsal skin sections from control and diabetic mice. Scale bars, 25 mm. (F) Quantification of the vessel numbers is displayed in the graph (n = 3). (G, H) Relative mRNA expression of IL-25 and IL-17RB in the wound skin from control and diabetic mice (n = 3). (I, J) Representative immunofluorescent staining for IL-17RB (red) and DAPI (blue) in skin sections of wound edge from control and diabetic mice. Scale bars, 20 mm. Quantification of the IL-17RB protein expression in the mice skin is shown in the histogram in J (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001.

    Article Snippet: Mouse anti-GAPDH antibody (Cat#: 60004-1-Ig) and rabbit anti-IL-17RB antibody (Cat#: 20673-1-AP) were obtained from Proteintech.

    Techniques: Control, Staining, Immunohistochemistry, Expressing

    FIGURE 4 | IL-25-upregulated-IL-17RB facilitates wound healing in diabetic mice by rescuing b-catenin expression. (A) Representative immunofluorescent staining for IL-17RB (red) and DAPI (blue) in wound edge skin (day 7 post injury) from groups of control (CON), diabetic (DM) and diabetic with rmIL-25 injection mice (DM + rmIL-25). Scale bars, 20 mm. (B) Quantification of IL-17RB in A is shown (n = 3). (C) Representative western blotting image of b-catenin and IL-17RB in wound skin (day 7 post injury) from groups of CON, DM and DM + rmIL-25. (D) Quantification analysis of b-catenin and IL-17RB protein in C is presented (n = 3). (E, F) Protein expression level of b-catenin (green) in wound skin (day 7 post injury) from group of CON, DM and DM + rmIL-25 was evaluated by immunofluorescent staining (E) and the quantification analysis was shown (n = 3) (F). Scale bars, 20 mm. (G) Representative immunofluorescent staining for b-catenin (green) and DAPI (blue) in wound edge skin from diabetic patients with DFU and normoglycemic individuals. Scale bars, 20 mm. (H) Quantification analysis of the b-catenin protein expression from G (n = 3). (I) b-catenin mRNA expression in the wound edge skin from diabetic patients with DFU (n = 11) and normoglycemic individuals (n = 7) was analyzed by qPCR. *P < 0.05, **P < 0.01, ***P < 0.001.

    Journal: Frontiers in immunology

    Article Title: Interleukin-25-Mediated-IL-17RB Upregulation Promotes Cutaneous Wound Healing in Diabetic Mice by Improving Endothelial Cell Functions.

    doi: 10.3389/fimmu.2022.809755

    Figure Lengend Snippet: FIGURE 4 | IL-25-upregulated-IL-17RB facilitates wound healing in diabetic mice by rescuing b-catenin expression. (A) Representative immunofluorescent staining for IL-17RB (red) and DAPI (blue) in wound edge skin (day 7 post injury) from groups of control (CON), diabetic (DM) and diabetic with rmIL-25 injection mice (DM + rmIL-25). Scale bars, 20 mm. (B) Quantification of IL-17RB in A is shown (n = 3). (C) Representative western blotting image of b-catenin and IL-17RB in wound skin (day 7 post injury) from groups of CON, DM and DM + rmIL-25. (D) Quantification analysis of b-catenin and IL-17RB protein in C is presented (n = 3). (E, F) Protein expression level of b-catenin (green) in wound skin (day 7 post injury) from group of CON, DM and DM + rmIL-25 was evaluated by immunofluorescent staining (E) and the quantification analysis was shown (n = 3) (F). Scale bars, 20 mm. (G) Representative immunofluorescent staining for b-catenin (green) and DAPI (blue) in wound edge skin from diabetic patients with DFU and normoglycemic individuals. Scale bars, 20 mm. (H) Quantification analysis of the b-catenin protein expression from G (n = 3). (I) b-catenin mRNA expression in the wound edge skin from diabetic patients with DFU (n = 11) and normoglycemic individuals (n = 7) was analyzed by qPCR. *P < 0.05, **P < 0.01, ***P < 0.001.

    Article Snippet: Mouse anti-GAPDH antibody (Cat#: 60004-1-Ig) and rabbit anti-IL-17RB antibody (Cat#: 20673-1-AP) were obtained from Proteintech.

    Techniques: Expressing, Staining, Control, Injection, Western Blot

    FIGURE 6 | IL-25 rescues the inactivation of Wnt/b-catenin pathway in vitro. (A, B) HUVECs were stimulated with increasing concentrations of rhIL-25 for 48 h under high glucose conditions (HG). b-catenin and cyclin D1 mRNA from untreated HUVEC and rhIL-25-treated HUVECs under HG conditions were analyzed by qPCR analysis (n = 3). (C) IL-17RB mRNA expression in HUVECs stimulated with 400 ng/mL rhIL-25 under HG conditions for 48 h (n = 3). (D, E) Western blotting analysis of b-catenin and IL-17RB and their quantification (n = 3). (F–I) Representative immunofluorescent staining images and quantification of b-catenin (F, G) and IL-17RB (H, I) in HUVECs exposed to high glucose and high glucose with rhIL-25 conditions for 48 h (n = 3). Scale bars, 60 mm. * and #P < 0.05, **P < 0.01, ***P < 0.001 (#compared with CON group, *compared with HG group). ns, no significance.

    Journal: Frontiers in immunology

    Article Title: Interleukin-25-Mediated-IL-17RB Upregulation Promotes Cutaneous Wound Healing in Diabetic Mice by Improving Endothelial Cell Functions.

    doi: 10.3389/fimmu.2022.809755

    Figure Lengend Snippet: FIGURE 6 | IL-25 rescues the inactivation of Wnt/b-catenin pathway in vitro. (A, B) HUVECs were stimulated with increasing concentrations of rhIL-25 for 48 h under high glucose conditions (HG). b-catenin and cyclin D1 mRNA from untreated HUVEC and rhIL-25-treated HUVECs under HG conditions were analyzed by qPCR analysis (n = 3). (C) IL-17RB mRNA expression in HUVECs stimulated with 400 ng/mL rhIL-25 under HG conditions for 48 h (n = 3). (D, E) Western blotting analysis of b-catenin and IL-17RB and their quantification (n = 3). (F–I) Representative immunofluorescent staining images and quantification of b-catenin (F, G) and IL-17RB (H, I) in HUVECs exposed to high glucose and high glucose with rhIL-25 conditions for 48 h (n = 3). Scale bars, 60 mm. * and #P < 0.05, **P < 0.01, ***P < 0.001 (#compared with CON group, *compared with HG group). ns, no significance.

    Article Snippet: Mouse anti-GAPDH antibody (Cat#: 60004-1-Ig) and rabbit anti-IL-17RB antibody (Cat#: 20673-1-AP) were obtained from Proteintech.

    Techniques: In Vitro, Expressing, Western Blot, Staining

    FIGURE 7 | Endogenous overexpression of IL-25 activates Wnt/b-catenin pathway. HUVECs that stably overexpress IL-25 (Lenti-IL-25-GFP-HUVECs) were constructed by using a lentiviral expression vector of human interleukin 25 with the unfused CopGFP protein at the C-terminus (Lenti-IL-25-GFP). The overexpression of IL-25 was verified by q-PCR and immunofluorescent staining assays. (A) Relative IL-25 mRNA expression in wild type (WT) and Lenti-IL-25-GFP-HUVECs (n = 3). (B) Immunofluorescent staining images of IL-25 (red), GFP (green) and DAPI (blue) in wild type (WT) and Lenti-IL-25-GFP-HUVECs. Scale bars, 20 mm. (C, D) Western blotting analysis of b-catenin and IL-17RB in WT and Lenti-IL-25-GFP-HUVECs and their quantification under normal glucose conditions (n = 3). (E, F) Western blotting analysis of b-catenin and IL-17RB in WT and Lenti-IL-25-GFP-HUVECs after exposure to high glucose conditions for 24 and 48 h and their quantification (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001. ns, no significance.

    Journal: Frontiers in immunology

    Article Title: Interleukin-25-Mediated-IL-17RB Upregulation Promotes Cutaneous Wound Healing in Diabetic Mice by Improving Endothelial Cell Functions.

    doi: 10.3389/fimmu.2022.809755

    Figure Lengend Snippet: FIGURE 7 | Endogenous overexpression of IL-25 activates Wnt/b-catenin pathway. HUVECs that stably overexpress IL-25 (Lenti-IL-25-GFP-HUVECs) were constructed by using a lentiviral expression vector of human interleukin 25 with the unfused CopGFP protein at the C-terminus (Lenti-IL-25-GFP). The overexpression of IL-25 was verified by q-PCR and immunofluorescent staining assays. (A) Relative IL-25 mRNA expression in wild type (WT) and Lenti-IL-25-GFP-HUVECs (n = 3). (B) Immunofluorescent staining images of IL-25 (red), GFP (green) and DAPI (blue) in wild type (WT) and Lenti-IL-25-GFP-HUVECs. Scale bars, 20 mm. (C, D) Western blotting analysis of b-catenin and IL-17RB in WT and Lenti-IL-25-GFP-HUVECs and their quantification under normal glucose conditions (n = 3). (E, F) Western blotting analysis of b-catenin and IL-17RB in WT and Lenti-IL-25-GFP-HUVECs after exposure to high glucose conditions for 24 and 48 h and their quantification (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001. ns, no significance.

    Article Snippet: Mouse anti-GAPDH antibody (Cat#: 60004-1-Ig) and rabbit anti-IL-17RB antibody (Cat#: 20673-1-AP) were obtained from Proteintech.

    Techniques: Over Expression, Stable Transfection, Construct, Expressing, Plasmid Preparation, Staining, Western Blot

    FIGURE 8 | IL-25 induces AKT and ERK 1/2 phosphorylation in HUVECs under high glucose conditions. (A, B) HUVECs were cultured in 6-well plate. After grown to 80%, cells were treated with high glucose medium in the presence of a gradient of rhIL-25. Proteins were collected for western blotting analysis after culturing for another 48 h. Representative western blotting images of p-AKT, p-ERK 1/2 and IL-17RB (A) and their quantification (B) (n = 3) were shown. (C, D) WT-HUVECs and Lenti-IL-25-GFP-HUVECs were cultured in normal glucose conditions and proteins were collected for western blotting analysis. Representative western blotting images of p-AKT and p-ERK 1/2 (C) and their quantification is displayed in the graph (D) (n = 3). (E, F) WT-HUVECs and Lenti-IL-25-GFP-HUVECs were treated with high glucose for 24 or 48 h and the proteins were obtained for western blotting analysis. Representative western blotting images (E) and quantification (F) of p-AKT and p-ERK 1/2 (n = 3) were shown. * and #P < 0.05, **P < 0.01, *** and ###P < 0.001 (#compared with CON group, *compared with HG group). ns, no significance.

    Journal: Frontiers in immunology

    Article Title: Interleukin-25-Mediated-IL-17RB Upregulation Promotes Cutaneous Wound Healing in Diabetic Mice by Improving Endothelial Cell Functions.

    doi: 10.3389/fimmu.2022.809755

    Figure Lengend Snippet: FIGURE 8 | IL-25 induces AKT and ERK 1/2 phosphorylation in HUVECs under high glucose conditions. (A, B) HUVECs were cultured in 6-well plate. After grown to 80%, cells were treated with high glucose medium in the presence of a gradient of rhIL-25. Proteins were collected for western blotting analysis after culturing for another 48 h. Representative western blotting images of p-AKT, p-ERK 1/2 and IL-17RB (A) and their quantification (B) (n = 3) were shown. (C, D) WT-HUVECs and Lenti-IL-25-GFP-HUVECs were cultured in normal glucose conditions and proteins were collected for western blotting analysis. Representative western blotting images of p-AKT and p-ERK 1/2 (C) and their quantification is displayed in the graph (D) (n = 3). (E, F) WT-HUVECs and Lenti-IL-25-GFP-HUVECs were treated with high glucose for 24 or 48 h and the proteins were obtained for western blotting analysis. Representative western blotting images (E) and quantification (F) of p-AKT and p-ERK 1/2 (n = 3) were shown. * and #P < 0.05, **P < 0.01, *** and ###P < 0.001 (#compared with CON group, *compared with HG group). ns, no significance.

    Article Snippet: Mouse anti-GAPDH antibody (Cat#: 60004-1-Ig) and rabbit anti-IL-17RB antibody (Cat#: 20673-1-AP) were obtained from Proteintech.

    Techniques: Phospho-proteomics, Cell Culture, Western Blot